Your browser doesn't support javascript.
loading
Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials.
Brown, Kari R; Baker, James; Vereda, Andrea; Beyer, Kirsten; Burks, A Wesley; du Toit, George; O'B Hourihane, Jonathan; Jones, Stacie M; Norval, David; Dana, Adrian; Shreffler, Wayne; Vickery, Brian P; Casale, Thomas; Skeel, Ben; Adelman, Daniel.
Afiliación
  • Brown KR; Aimmune Therapeutics, a Nestlé Health Science company, Brisbane, Calif. Electronic address: kbrown@aimmune.com.
  • Baker J; Mary H. Weiser Food Allergy Center, University of Michigan, Ann Arbor, Mich.
  • Vereda A; Aimmune Therapeutics, a Nestlé Health Science company, London, United Kingdom.
  • Beyer K; Charité Universitãtsmedizin Berlin, Berlin, Germany.
  • Burks AW; Department of Pediatrics, University of North Carolina Food Allergy Initiative, Division of Allergy, Immunology and Rheumatology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • du Toit G; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • O'B Hourihane J; Paediatrics and Child Health, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Jones SM; University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, Ark.
  • Norval D; Aimmune Therapeutics, a Nestlé Health Science company, London, United Kingdom.
  • Dana A; Aimmune Therapeutics, a Nestlé Health Science company, Brisbane, Calif.
  • Shreffler W; Massachusetts General Hospital, Boston, Mass.
  • Vickery BP; Emory University School of Medicine, Atlanta, Ga.
  • Casale T; University of South Florida, Tampa, Fla.
  • Skeel B; Aimmune Therapeutics, a Nestlé Health Science company, London, United Kingdom.
  • Adelman D; Aimmune Therapeutics, a Nestlé Health Science company, Brisbane, Calif; Department of Medicine, University of California San Francisco, San Francisco, Calif.
J Allergy Clin Immunol ; 149(6): 2043-2052.e9, 2022 06.
Article en En | MEDLINE | ID: mdl-34971646

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hipersensibilidad al Cacahuete Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adolescent / Child / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hipersensibilidad al Cacahuete Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adolescent / Child / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article